MedPath

Endoscopic Band Ligation (EBL) Versus Endoscopic Band Ligation and Propranolol for the Prevention of Variceal Rebleeding

Phase 4
Conditions
Cirrhosis
Variceal Bleeding
Interventions
Procedure: EBL+Propranolol
Procedure: endoscopic band ligation
Registration Number
NCT00966121
Lead Sponsor
Korea University
Brief Summary

Both propranolol and endoscopic band ligation (EBL) are effective for prevention of variceal rebleeding. Recently several studies compared the efficacy of EBL alone and with a combination of propranolol and EBL. However, the results of recent studies showed discrepancy. This study is performed to compare the efficacy and safety of EBL alone and EBL combined with propranolol in patients without previous history of endoscopic variceal treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
180
Inclusion Criteria
  • liver cirrhosis
  • age between 18 and 70 years
  • Successful control of esophageal variceal bleeding within 6 weeks before enrollment
Exclusion Criteria
  • Gastric variceal bleeding
  • Patients with systolic blood pressure <100 mmHg or basal heart rate <60/min
  • Portal vein thrombosis
  • Prominent hepatic encephalopathy
  • Coexisting untreated malignancy
  • Severe cerebrovascular or cardiovascular disease, renal failure
  • Previous history of endoscopic, radiologic, or surgical treatment for varices or ascites
  • Contraindication to beta-blocker
  • Pregnancy
  • Refusal to give consent to participate in the trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
EBL+PropranololEBL+PropranololPerform EBL same as EBL group. In addition, take propranolol to reduce 25% in HR or HR ≤55/min
Endoscopic band ligationendoscopic band ligationPerform endoscopic band ligation (EBL) until esophageal varices are eradicated, and then follow-up endoscopy with 3-6 months interval
Primary Outcome Measures
NameTimeMethod
Rebleeding from esophageal varices2 years

Rebleeding from esophageal varices

Secondary Outcome Measures
NameTimeMethod
Upper gastrointestinal bleeding; significant esophageal variceal bleeding; mortality;adverse events2 years

Upper gastrointestinal bleeding; significant esophageal variceal bleeding; mortality;adverse events

Trial Locations

Locations (1)

Korea University Anam Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath